Leandro Bueno Bergantin Author
Subjects of specialization
Affiliation
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker
Department of Pharmacology, Universidade Federal de S
Leandro Bueno Bergantin was working in the Department of Pharmacology, Universidade Federal de São Paulo, Escola Paulista de Medicina, Laboratory of Autonomic and Cardiovascular Pharmacology, Brazil. Doctor has more than 100 publications. Doctor's current research area related to Clinical Oncology.
Editorial Open Access
Author(s): Paolo Ruggero Errante, Francisco Sandro Menezes-Rodrigues, Afonso Caricati-Neto and Leandro Bueno Bergantin
Cancer is a major public health issue worldwide, affecting both developed and developing countries, thus leading to the rise of a large annual expenses every fiscal year. Surgery, radiotherapy, chemotherapy, immunotherapy and multitarget pharmaceutical therapies are the current strategies for cancer treatment. Generally, cancer treatments are based on the clinical history of the patients, including histological type and the presence of molecular biomarkers. Nonetheless, new options are clearly needed to increase survival and improve the patients’ quality of life, especially for those in advanced stages of this disease. Thus, the increased knowledge of the mechanisms responsible for growth, invasion and metastasis of cancer, including development of int... view moreĀ»